Deprescribing Proton Pump Inhibitors in an Academic, Primary Care Clinic Quality Improvement Project

被引:14
|
作者
Nallapeta, Naren [1 ]
Reynolds, Jessica L. [2 ]
Bakhai, Smita [3 ]
机构
[1] Univ Buffalo State Univ New York, Dept Internal Med, Buffalo, NY 14215 USA
[2] Univ Buffalo State Univ New York, Dept Med, Buffalo, NY 14215 USA
[3] Univ Buffalo State Univ New York, ECMC, Dept Internal Med, Suite 15,462 Grider St, Buffalo, NY 14215 USA
基金
美国国家卫生研究院;
关键词
proton pump inhibitors; quality improvement; evidence-based guidelines; deprescribing PPI; primary care; inappropriate use of PPI; COMMUNITY-ACQUIRED PNEUMONIA; LONG-TERM USE; RISK; THERAPY; INFECTION; BENEFITS; OVERUSE; NEED;
D O I
10.1097/MCG.0000000000001317
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Goal: The goal of this study was to reduce the percentage of inappropriately prescribed proton pump inhibitors (PPIs) in patients aged 50 and older from 80% (baseline) to 60% within 12 months in an academic, internal medicine clinic. Background: The use of PPIs has increased drastically worldwide. Internal medicine clinic patients had inappropriate use of PPIs for an average of 4 to 5 years. Study: A multidisciplinary quality improvement team used the Plan-Do-Study-Act Model of health care improvement and performed a root cause analysis to identify barriers to inappropriate use of PPIs. The outcome measure was the percentage of patients inappropriately prescribed PPI. Process measures were completion rates of PPI risk assessment and esophagogastroduodenoscopy. Interventions included the creation of customized electronic health record templates and education to providers and patients. Analysis was performed using monthly statistical process control charts. Results: The average rate of PPI discontinuation was 51.1% (n=92/180), which corresponds to 30.0% inappropriate PPI usage within 12 months. The mean PPI discontinuation rate in the 1-year prestudy, study and 6 months poststudy period was 2.0%, 32.0%, and 49.7%, respectively. The mean esophagogastroduodenoscopy completion rate was 49.8% from the baseline of Conclusions: We achieved a statistically significant and sustainable reduction of inappropriate PPI use to 30% from the baseline rates of 80% and surpassed our goal within 12 months. This quality improvement was unique as no pharmacy personnel was utilized in this process. The multifaceted strategies in a safety-net internal medicine clinic resulted in successful deprescribing of PPI and can be replicated in other setting.
引用
收藏
页码:864 / 870
页数:7
相关论文
共 50 条
  • [21] Use of proton pump inhibitors among older Australians: national quality improvement programmes have led to sustained practice change
    Pratt, Nicole L.
    Ellett, Lisa M. Kalisch
    Sluggett, Janet K.
    Gadzhanova, Svetla V.
    Ramsay, Emmae N.
    Kerr, Mhairi
    Leblanc, Vanessa T.
    Barratt, John D.
    Roughead, Elizabeth E.
    INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2017, 29 (01) : 75 - 82
  • [22] Deprescribing proton pump inhibitors: A study in hospitalized patients in Slovenia
    Ravbar, Nina
    Kos, Mojca Kerec
    Jost, Maja
    Lipovec, Nanca Cebron
    Knez, Lea
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2023, 61 (07) : 306 - 314
  • [23] Analysis of deprescription strategies of proton pump inhibitors in primary care: a narrative review
    Del-Pino, Miguel
    Sanz, Emilio J.
    PRIMARY HEALTH CARE RESEARCH AND DEVELOPMENT, 2023, 24
  • [24] Deprescribing in primary care without deterioration of health-related outcomes: A real-life, quality improvement project
    Olesen, Anne Estrup
    Vaever, Tanja Joest
    Simonsen, Martin
    Simonsen, Peter Gaardbo
    Hoj, Kirsten
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 134 (01) : 72 - 82
  • [25] Improving compliance with diabetes care using a novel mnemonic: A quality improvement project in an urban primary care clinic
    Tabingo, Neander
    Verzone, Ana
    PRIMARY CARE DIABETES, 2020, 14 (06) : 714 - 722
  • [26] Physicians' views on pharmacists' involvement in hospital deprescribing: A qualitative study on proton pump inhibitors
    Gendre, Pauline
    Mayol, Severine
    Mocquard, Julie
    Huon, Jean-Francois
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2023, 133 (06) : 718 - 728
  • [27] Suitability of patient education materials on proton-pump inhibitors deprescribing: a focused review
    Jérôme Nguyen-Soenen
    Cédric Rat
    Jean-Pascal Fournier
    European Journal of Clinical Pharmacology, 2020, 76 : 17 - 21
  • [28] Peer-Led Education Expedites Deprescribing Proton Pump Inhibitors for Appropriate Veterans
    Bowman, Mary H.
    GASTROENTEROLOGY NURSING, 2020, 43 (03) : 218 - 224
  • [29] A Breastfeeding Quality Improvement Project in Rural Primary Care
    Dumphy, Deborah
    Thompson, Julie
    Clark, Myra
    JOURNAL OF HUMAN LACTATION, 2016, 32 (04) : 633 - 641
  • [30] The monitoring of DOACs in primary care, a quality improvement project
    Muhid, Abdul
    Khan, Javed
    WORLD FAMILY MEDICINE, 2022, 20 (09): : 60 - 64